“Daily Practice Use of Bortezomib in Relapsed Refractory Multiple Myeloma: Safety Efficacy Results of a Compassionate Use Program in Switzerland”. Swiss Medical Weekly 137, no. 2122 (June 2, 2007): 317–322. Accessed October 18, 2025. https://smw.ch/index.php/smw/article/view/736.